MedPath

Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors

Not Applicable
Completed
Conditions
Cancer
Interventions
Behavioral: Cognitive-Behavioral Stress Management and Health Education
Registration Number
NCT05054569
Lead Sponsor
Northwestern University
Brief Summary

The purpose of this study is to develop and pre-test an eHealth group intervention for young adult cancer survivors.

Detailed Description

In the first part of this study, the investigators adapted an evidence-based intervention for improving HRQOL to better meet the needs of young adult cancer survivors, and then conducted focus groups with young adult cancer survivors to get feedback on the adapted intervention. In the second part of the study, the investigators will conduct a single-arm pilot trial in which the adapted intervention will be delivered over videoconference via weekly group meetings with a trained facilitator over the course of 10 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • age 18-39 years at the time of participation
  • diagnosed with a non-metastatic primary cancer between 18-39 years old
  • completed primary cancer treatment (excepting hormone therapy) 1 month to 5 years prior to enrollment
  • able to speak and read English
  • access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences
Exclusion Criteria
  • metastatic disease
  • psychiatric or neurological disorders that could interfere with study participation
  • considered part of a vulnerable population

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
10-week eHealth interventionCognitive-Behavioral Stress Management and Health EducationWeekly video conference groups led by a trained facilitator
Primary Outcome Measures
NameTimeMethod
Acceptability of the adapted interventionImmediately after the intervention

Immediately after the intervention participants will report their satisfaction with the full program through a brief survey.

Secondary Outcome Measures
NameTimeMethod
Change in coping from baseline to immediately after the interventionBaseline and immediately after the intervention

Participants will complete the Brief Coping Orientation to Problems Experienced scale, which yields 14 two-item subscales. Subscale scores range from 2 to 8, with higher scores indicating greater usage of the coping strategy being assessed.

Change in cancer-related distress from baseline to immediately after the interventionBaseline and immediately after the intervention

Participants will complete the 22-item Impact of Event Scale-Revised. Scores range from 0 to 88, with higher scores indicating greater cancer-related distress.

Change in stress management skills self-efficacy from baseline to immediately after the interventionBaseline and immediately after the intervention

Participants will complete subscales from the Measure of Current Status. Subscale scores range from 0 to 8, 0 to 12, or 0 to 20 depending on the subscale. Higher scores indicate more of the construct being assessed.

Change in symptom burden from baseline to immediately after the interventionBaseline and immediately after the intervention

Participants will complete a modified version of the Edmonton Symptom Assessment Scale, which assesses 10 common cancer-related symptoms each on a numerical rating scale ranging from 0 to 10. Higher scores indicate greater symptom burden.

Change in health-related quality of life (HRQOL) from baseline to immediately after the interventionBaseline and immediately after the intervention

Participants will complete the 27-item Functional Assessment of Cancer Therapy - General. Scores range from 0 to 108, with higher scores reflecting better quality of life.

Trial Locations

Locations (1)

Northwestern University Feinberg School of Medicine

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath